ADGM · ADAGIO MED HLDGS INC
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Market Cap
3.589M
52 Wk Range
$0.12 - $2.02
Previous Close
$0.13
Open
$0.13
Volume
754,756
Day Range
$0.12 - $0.14
Enterprise Value
23.32M
Cash
7.74M
Avg Qtr Burn
-5.26M
Insider Ownership
0.95%
Institutional Own.
55.44%
Qtr Updated
Jun 30th 2026
